HOME › DRUGS › TAFASITAMAB
ACTIVE SUBSTANCE / INN

TAFASITAMAB

Brand name(s): Minjuvi
EMA LISTED
AUTHORISED
Lymphoma, Large B-Cell, Diffuse
ACTIVE SUBSTANCE
Tafasitamab
REGULATORS
EMA
SPONSORS / MAH
Incyte Biosciences Distribution B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MinjuviIncyte Biosciences Distribution B.V.Authorised26/08/2021Lymphoma, Large B-Cell, Diffuse

FULL INTELLIGENCE ON TAFASITAMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →